Pictet Asset Management Holding SA Sells 4,416 Shares of Cigna Group $CI

Pictet Asset Management Holding SA cut its holdings in Cigna Group (NYSE:CI) by 2.3% during the 4th quarter, Holdings Channel reports. The firm owned 187,517 shares of the health services provider’s stock after selling 4,416 shares during the period. Pictet Asset Management Holding SA’s holdings in Cigna Group were worth $51,611,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Harbor Capital Advisors Inc. grew its position in shares of Cigna Group by 119.5% in the 3rd quarter. Harbor Capital Advisors Inc. now owns 90 shares of the health services provider’s stock worth $26,000 after buying an additional 49 shares during the period. Beacon Financial Strategies CORP purchased a new stake in shares of Cigna Group during the fourth quarter valued at $28,000. Lodestone Wealth Management LLC bought a new position in Cigna Group during the 4th quarter valued at about $32,000. Collier Financial purchased a new position in shares of Cigna Group in the 3rd quarter worth $34,000. Finally, True Wealth Design LLC increased its position in shares of Cigna Group by 116.4% during the 4th quarter. True Wealth Design LLC now owns 158 shares of the health services provider’s stock valued at $43,000 after purchasing an additional 85 shares during the last quarter. 86.99% of the stock is owned by hedge funds and other institutional investors.

Cigna Group Stock Performance

Shares of CI stock opened at $292.16 on Thursday. The company has a current ratio of 0.74, a quick ratio of 0.74 and a debt-to-equity ratio of 0.74. The company has a market cap of $76.99 billion, a PE ratio of 13.17, a PEG ratio of 0.98 and a beta of 0.26. The business’s fifty day simple moving average is $274.24 and its 200-day simple moving average is $276.84. Cigna Group has a 12-month low of $239.51 and a 12-month high of $350.00.

Cigna Group (NYSE:CI) last issued its quarterly earnings results on Thursday, February 5th. The health services provider reported $8.08 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.88 by $0.20. The business had revenue of $72.50 billion for the quarter, compared to analyst estimates of $69.53 billion. Cigna Group had a net margin of 2.17% and a return on equity of 19.46%. Cigna Group’s revenue for the quarter was up 10.4% compared to the same quarter last year. During the same quarter in the prior year, the business posted $6.64 EPS. Cigna Group has set its FY 2026 guidance at 30.250- EPS. Analysts expect that Cigna Group will post 30.32 earnings per share for the current fiscal year.

Cigna Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, June 18th. Stockholders of record on Thursday, June 4th will be issued a $1.56 dividend. This represents a $6.24 annualized dividend and a dividend yield of 2.1%. The ex-dividend date of this dividend is Thursday, June 4th. Cigna Group’s payout ratio is 28.13%.

Analysts Set New Price Targets

CI has been the topic of several recent research reports. Barclays decreased their price objective on Cigna Group from $305.00 to $303.00 and set an “overweight” rating on the stock in a research note on Friday, February 6th. Guggenheim restated a “buy” rating and issued a $318.00 target price on shares of Cigna Group in a report on Monday, February 2nd. UBS Group reaffirmed a “buy” rating and set a $375.00 price target on shares of Cigna Group in a research note on Monday, February 9th. Leerink Partners raised their price target on Cigna Group from $270.00 to $297.00 and gave the stock a “market perform” rating in a research note on Friday, February 6th. Finally, Deutsche Bank Aktiengesellschaft raised their target price on shares of Cigna Group from $301.00 to $304.00 and gave the stock a “buy” rating in a research report on Tuesday, February 10th. One research analyst has rated the stock with a Strong Buy rating, sixteen have given a Buy rating and four have assigned a Hold rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $332.47.

Insider Activity

In other Cigna Group news, insider Nicole S. Jones sold 2,307 shares of Cigna Group stock in a transaction on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total value of $666,515.37. Following the completion of the transaction, the insider owned 32,647 shares of the company’s stock, valued at approximately $9,432,044.77. The trade was a 6.60% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Everett Neville sold 1,719 shares of the firm’s stock in a transaction dated Monday, March 2nd. The shares were sold at an average price of $288.91, for a total value of $496,636.29. Following the sale, the insider owned 5,670 shares in the company, valued at $1,638,119.70. This trade represents a 23.26% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 0.60% of the stock is owned by company insiders.

Cigna Group Company Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.